Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Not applicable Interventional

Embecta AID System in Adults With Type 2 Diabetes

ClinicalTrials.gov ID: NCT06692153

Public ClinicalTrials.gov record NCT06692153. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 1:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Pivotal, Randomized Controlled Trial Comparing the Safety and Efficacy of an Automated Insulin Delivery System With the Standard of Care in Adults With Type 2 Diabetes (EMBRACE-T2D)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, randomized control study that will evaluate the safety and effectiveness of the embecta Automated Insulin Delivery System in adults with Type 2 diabetes requiring insulin therapy

Study identification

NCT ID
NCT06692153
Recruitment status
Withdrawn
Study type
Interventional
Phase
Not applicable
Lead sponsor
Embecta Corp.
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2024
Primary completion
Feb 28, 2026
Completion
Apr 30, 2026
Last update posted
Dec 15, 2024

2025 – 2026

United States locations

U.S. sites
9
U.S. states
5
U.S. cities
9
Facility City State ZIP Site status
Stanford Palo Alto California 94304
Diablo Research Walnut Creek California 94598
Indiana Universtiy School of Medicine Indianapolis Indiana 46202
NYC Research Long Island City New York 11106
Icahn School of Medicine at Mt. Sinai New York New York 10029
UT Southwestern Dallas Texas 10029
Tekton Research Irving Texas 75039
Texas Diabetes & Endocrinology Round Rock Texas 78681
DETS Utah Sandy City Utah 84093

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06692153, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2024 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06692153 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →